| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Canada | 5 | |
| #2 | Australia | 3 | |
| #3 | Israel | 3 | |
| #4 | WIPO (World Intellectual Property Organization) | 3 | |
| #5 | EPO (European Patent Office) | 2 | |
| #6 | China | 1 | |
| #7 | Republic of Korea | 1 | |
| #8 | New Zealand | 1 | |
| #9 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement | |
| #4 | Foods and drinks | |
| #5 | Micro-structure and nano-technology | |
| #6 | Environmental technology |
| # | Name | Total Patents |
|---|---|---|
| #1 | Larsen Bjarne Due | 11 |
| #2 | Petersen Jorgen Soberg | 4 |
| #3 | Holm Arne | 4 |
| #4 | Lukas Claudia | 3 |
| #5 | Lukas Jiri | 3 |
| #6 | Bartek Jiri | 3 |
| #7 | Syljuasen Randi | 3 |
| #8 | Mikkelsen Jens Damsgaard | 3 |
| #9 | Kapusta Daniel R | 3 |
| #10 | Falck Jakob | 2 |
| Publication | Filing date | Title |
|---|---|---|
| WO0228412A1 | Novel use of peptide | |
| AU6709301A | Novel use of peptide | |
| EP1076066A1 | Peptides for lowering blood glucose levels | |
| CA2321026A1 | Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis | |
| KR20000036015A | Peptide prodrugs containing an alpha-hydroxyacid linker |